Portfolio Holdings Detail for ISIN IE00BF4RFH31
| Stock Name / Fund | iShares MSCI World Small Cap UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares III Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300PZLRJB7M8H1057 |
| ETF Ticker | WSML(USD) LSE |
| ETF Ticker | WLDS(GBP) LSE |
| ETF Ticker | IUSN(EUR) F |
| ETF Ticker | IUSN.DE(EUR) CXE |
| ETF Ticker | WLDS.LS(GBP) CXE |
| ETF Ticker | WSML.LS(USD) CXE |
| ETF Ticker | WSML.L(GBP) LSE |
| ETF Ticker | WLDS.L(GBP) LSE |
Holdings detail for CRSP
| Stock Name | Crispr Therapeutics AG |
| Ticker | CRSP(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | CH0334081137 |
| LEI | 506700O6IRRIQLT3W370 |
Show aggregate CRSP holdings
News associated with CRSP
- CRISPR Therapeutics AG (NASDAQ:CRSP) Given Consensus Recommendation of “Hold” by Analysts
- Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) have been assigned a consensus recommendation of “Hold” from the twenty-one ratings firms that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and eleven have given a buy rating […] - 2025-03-13 06:53:04
- BBMC's Underlying Holdings Could Mean 22% Gain Potential
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-06 12:34:24
- 3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.
- Investors looking for growth in recent times have piled into stocks in artificial intelligence and quantum computing. But these aren't the only areas that offer the potential for explosive revenue growth and stock performance. Another industry also offers innovation and even gam - 2025-02-28 08:15:00
- CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Acquired by State of New Jersey Common Pension Fund D
- State of New Jersey Common Pension Fund D boosted its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 10.8% during the 4th quarter, Holdings Channel reports. The fund owned 44,692 shares of the company’s stock after acquiring an additional 4,351 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings […] - 2025-02-26 08:31:02
- CRISPR Therapeutics (NASDAQ:CRSP) Shares Down 4.7% Following Insider Selling
- CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s share price was down 4.7% during mid-day trading on Monday after an insider sold shares in the company. The stock traded as low as $45.16 and last traded at $45.65. Approximately 914,670 shares traded hands during mid-day trading, a decline of 62% from the average daily volume […] - 2025-02-26 06:24:52
- Allworth Financial LP Purchases 14,398 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)
- Allworth Financial LP lifted its position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 2,117.4% during the fourth quarter, Holdings Channel.com reports. The firm owned 15,078 shares of the company’s stock after buying an additional 14,398 shares during the quarter. Allworth Financial LP’s holdings in CRISPR Therapeutics were worth $593,000 as of […] - 2025-02-21 08:38:56
- Vontobel Holding Ltd. Trims Position in CRISPR Therapeutics AG (NASDAQ:CRSP)
- Vontobel Holding Ltd. trimmed its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 11.1% during the 4th quarter, Holdings Channel.com reports. The firm owned 15,068 shares of the company’s stock after selling 1,889 shares during the period. Vontobel Holding Ltd.’s holdings in CRISPR Therapeutics were worth $593,000 as of its most recent SEC […] - 2025-02-20 09:08:52
- Citigroup Lowers CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $82.00
- CRISPR Therapeutics (NASDAQ:CRSP – Free Report) had its target price decreased by Citigroup from $89.00 to $82.00 in a report released on Tuesday morning,Benzinga reports. Citigroup currently has a buy rating on the stock. Several other brokerages have also recently weighed in on CRSP. Needham & Company LLC reiterated a “buy” rating and set a […] - 2025-02-19 10:14:57
- Valeo Financial Advisors LLC Reduces Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP)
- Valeo Financial Advisors LLC reduced its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 15.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,358 shares of the company’s stock after selling 1,175 shares during the period. Valeo Financial Advisors LLC’s holdings […] - 2025-02-19 09:38:55
- CRISPR Therapeutics Target of Unusually Large Options Trading (NASDAQ:CRSP)
- CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) saw unusually large options trading on Tuesday. Stock traders bought 13,128 call options on the stock. This is an increase of approximately 59% compared to the average volume of 8,282 call options. Insiders Place Their Bets In other news, CEO Samarth Kulkarni sold 15,000 shares of the […] - 2025-02-19 08:59:33
- Brokerages Set CRISPR Therapeutics AG (NASDAQ:CRSP) Target Price at $74.50
- CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty-two analysts that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation and twelve have assigned a buy recommendation to the company. The average […] - 2025-02-19 06:46:55
- CRISPR Therapeutics (NASDAQ:CRSP) Earns Buy Rating from HC Wainwright
- HC Wainwright reissued their buy rating on shares of CRISPR Therapeutics (NASDAQ:CRSP – Free Report) in a research note issued to investors on Thursday morning,Benzinga reports. The firm currently has a $65.00 price objective on the stock. Several other research analysts have also commented on the stock. Truist Financial lifted their price target on shares […] - 2025-02-16 10:49:00
- CRISPR Therapeutics (NASDAQ:CRSP) Upgraded at StockNews.com
- StockNews.com upgraded shares of CRISPR Therapeutics (NASDAQ:CRSP – Free Report) to a sell rating in a research report released on Thursday. Other analysts have also issued reports about the stock. Needham & Company LLC reissued a “buy” rating and set a $84.00 price target on shares of CRISPR Therapeutics in a research report on Wednesday. […] - 2025-02-16 10:48:55
- CRISPR Therapeutics (NASDAQ:CRSP) Given New $120.00 Price Target at Truist Financial
- CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target hoisted by equities researchers at Truist Financial from $100.00 to $120.00 in a report issued on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Truist Financial’s price target points to a potential upside of 175.93% from the stock’s previous close. […] - 2025-02-14 09:16:56
- CRISPR Therapeutics (NASDAQ:CRSP) Price Target Raised to $56.00
- CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target hoisted by Barclays from $55.00 to $56.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Barclays‘s price target suggests a potential upside of 28.77% from the company’s current price. Several other equities […] - 2025-02-14 09:16:49
- Contrasting CRISPR Therapeutics (NASDAQ:CRSP) and Athira Pharma (NASDAQ:ATHA)
- CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) and Athira Pharma (NASDAQ:ATHA – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability and institutional ownership. Valuation and Earnings This table compares CRISPR Therapeutics […] - 2025-02-14 08:34:47
- March 28th Options Now Available For CRISPR Therapeutics (CRSP)
- Investors in CRISPR Therapeutics AG (Symbol: CRSP) saw new options begin trading today, for the March 28th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRSP options chain for the new March 28th contracts and identified one put and one - 2025-02-06 18:31:23
- CRISPR Therapeutics (NASDAQ:CRSP) Now Covered by HC Wainwright
- HC Wainwright initiated coverage on shares of CRISPR Therapeutics (NASDAQ:CRSP – Free Report) in a research report sent to investors on Monday, MarketBeat reports. The brokerage issued a buy rating and a $65.00 price objective on the stock. A number of other analysts have also commented on the stock. Chardan Capital reaffirmed a “buy” rating […] - 2025-02-04 08:41:05
- PFG Investments LLC Grows Stake in CRISPR Therapeutics AG (NASDAQ:CRSP)
- PFG Investments LLC lifted its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,603 shares of the company’s stock after buying an additional 952 shares during the period. PFG Investments […] - 2025-01-31 09:37:09
- Exchange Traded Concepts LLC Decreases Stake in CRISPR Therapeutics AG (NASDAQ:CRSP)
- Exchange Traded Concepts LLC trimmed its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 16.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 16,127 shares of the company’s stock after selling 3,065 shares during the quarter. Exchange Traded […] - 2025-01-31 08:34:51
iShares MSCI World Small Cap UCITS ETF USD (Acc) CRSP holdings
| Date | Number of CRSP Shares Held | Base Market Value of CRSP Shares | Local Market Value of CRSP Shares | Change in CRSP Shares Held | Change in CRSP Base Value | Current Price per CRSP Share Held | Previous Price per CRSP Share Held |
|---|
| 2025-03-12 (Wednesday) | 49,262 | USD 2,142,404 | USD 2,142,404 | -232 | USD 45,343 | USD 43.49 | USD 42.37 |
| 2025-03-11 (Tuesday) | 49,494 | USD 2,097,061 | USD 2,097,061 | 0 | USD -48,009 | USD 42.37 | USD 43.34 |
| 2025-03-10 (Monday) | 49,494 | USD 2,145,070 | USD 2,145,070 | 0 | USD -108,392 | USD 43.34 | USD 45.53 |
| 2025-03-07 (Friday) | 49,494 | USD 2,253,462 | USD 2,253,462 | 0 | USD 83,645 | USD 45.53 | USD 43.84 |
| 2025-03-05 (Wednesday) | 49,494 | USD 2,169,817 | USD 2,169,817 | 0 | USD 19,303 | USD 43.84 | USD 43.45 |
| 2025-03-04 (Tuesday) | 49,494 | USD 2,150,514 | USD 2,150,514 | -230 | USD 47,686 | USD 43.45 | USD 42.29 |
| 2025-03-03 (Monday) | 49,724 | USD 2,102,828 | USD 2,102,828 | 0 | USD -81,050 | USD 42.29 | USD 43.92 |
| 2025-02-28 (Friday) | 49,724 | USD 2,183,878 | USD 2,183,878 | 0 | USD 14,917 | USD 43.92 | USD 43.62 |
| 2025-02-27 (Thursday) | 49,724 | USD 2,168,961 | USD 2,168,961 | 0 | USD -38,785 | USD 43.62 | USD 44.4 |
| 2025-02-26 (Wednesday) | 49,724 | USD 2,207,746 | USD 2,207,746 | -460 | USD -25,944 | USD 44.4 | USD 44.51 |
| 2025-02-25 (Tuesday) | 50,184 | USD 2,233,690 | USD 2,233,690 | 0 | USD -103,379 | USD 44.51 | USD 46.57 |
| 2025-02-24 (Monday) | 50,184 | USD 2,337,069 | USD 2,337,069 | 0 | USD -67,246 | USD 46.57 | USD 47.91 |
| 2025-02-21 (Friday) | 50,184 | USD 2,404,315 | USD 2,404,315 | 0 | USD -126,464 | USD 47.91 | USD 50.43 |
| 2025-02-20 (Thursday) | 50,184 | USD 2,530,779 | USD 2,530,779 | 0 | USD -129,977 | USD 50.43 | USD 53.02 |
| 2025-02-19 (Wednesday) | 50,184 | USD 2,660,756 | USD 2,660,756 | 0 | USD 40,148 | USD 53.02 | USD 52.22 |
| 2025-02-18 (Tuesday) | 50,184 | USD 2,620,608 | USD 2,620,608 | 0 | USD 125,460 | USD 52.22 | USD 49.72 |
| 2025-02-17 (Monday) | 50,184 | USD 2,495,148 | USD 2,495,148 | 0 | USD 0 | USD 49.72 | USD 49.72 |
| 2025-02-14 (Friday) | 50,184 | USD 2,495,148 | USD 2,495,148 | 0 | USD 312,646 | USD 49.72 | USD 43.49 |
| 2025-02-13 (Thursday) | 50,184 | USD 2,182,502 | USD 2,182,502 | 117 | USD 14,601 | USD 43.49 | USD 43.3 |
| 2025-02-12 (Wednesday) | 50,067 | USD 2,167,901 | USD 2,167,901 | 468 | USD 202,789 | USD 43.3 | USD 39.62 |
| 2025-02-11 (Tuesday) | 49,599 | USD 1,965,112 | USD 1,965,112 | 0 | USD 10,415 | USD 39.62 | USD 39.41 |
| 2025-02-10 (Monday) | 49,599 | USD 1,954,697 | USD 1,954,697 | 0 | USD -14,879 | USD 39.41 | USD 39.71 |
| 2025-02-07 (Friday) | 49,599 | USD 1,969,576 | USD 1,969,576 | 0 | USD -44,639 | USD 39.71 | USD 40.61 |
| 2025-02-06 (Thursday) | 49,599 | USD 2,014,215 | USD 2,014,215 | 0 | USD -79,855 | USD 40.61 | USD 42.22 |
| 2025-02-05 (Wednesday) | 49,599 | USD 2,094,070 | USD 2,094,070 | 0 | USD 85,806 | USD 42.22 | USD 40.49 |
| 2025-02-04 (Tuesday) | 49,599 | USD 2,008,264 | USD 2,008,264 | 0 | USD 24,304 | USD 40.49 | USD 40 |
| 2025-02-03 (Monday) | 49,599 | USD 1,983,960 | USD 1,983,960 | 0 | USD -78,862 | USD 40 | USD 41.59 |
| 2025-01-31 (Friday) | 49,599 | USD 2,062,822 | USD 2,062,822 | 0 | USD -22,320 | USD 41.59 | USD 42.04 |
| 2025-01-30 (Thursday) | 49,599 | USD 2,085,142 | USD 2,085,142 | 0 | USD 41,167 | USD 42.04 | USD 41.21 |
| 2025-01-29 (Wednesday) | 49,599 | USD 2,043,975 | USD 2,043,975 | 0 | USD -29,759 | USD 41.21 | USD 41.81 |
| 2025-01-28 (Tuesday) | 49,599 | USD 2,073,734 | USD 2,073,734 | 0 | USD -1,984 | USD 41.81 | USD 41.85 |
| 2025-01-27 (Monday) | 49,599 | USD 2,075,718 | USD 2,075,718 | 116 | USD -72,834 | USD 41.85 | USD 43.42 |
| 2025-01-24 (Friday) | 49,483 | USD 2,148,552 | USD 2,148,552 | 0 | USD -40,081 | USD 43.42 | USD 44.23 |
| 2025-01-23 (Thursday) | 49,483 | USD 2,188,633 | USD 2,188,633 | 116 | USD 6,612 | USD 44.23 | USD 44.2 |
| 2025-01-22 (Wednesday) | 49,367 | USD 2,182,021 | USD 2,182,021 | 0 | USD 132,797 | USD 44.2 | USD 41.51 |
| 2025-01-22 (Wednesday) | 49,367 | USD 2,182,021 | USD 2,182,021 | 0 | USD 132,797 | USD 44.2 | USD 41.51 |
| 2025-01-21 (Tuesday) | 49,367 | USD 2,049,224 | USD 2,049,224 | | | | |
| 2025-01-20 (Monday) | 49,367 | USD 2,000,845 | USD 2,000,845 | | | | |
| 2025-01-17 (Friday) | 49,367 | USD 2,000,845 | USD 2,000,845 | | | | |
| 2025-01-16 (Thursday) | 49,367 | USD 1,989,490 | USD 1,989,490 | | | | |
| 2025-01-15 (Wednesday) | 49,367 | USD 1,927,288 | USD 1,927,288 | | | | |
| 2025-01-14 (Tuesday) | 49,367 | USD 1,893,718 | USD 1,893,718 | | | | |
| 2025-01-13 (Monday) | 49,367 | USD 1,917,908 | USD 1,917,908 | | | | |
| 2025-01-10 (Friday) | 49,367 | USD 1,959,376 | USD 1,959,376 | | | | |
| 2025-01-09 (Thursday) | 49,367 | USD 2,038,363 | USD 2,038,363 | | | | |
| 2025-01-09 (Thursday) | 49,367 | USD 2,038,363 | USD 2,038,363 | | | | |
| 2025-01-09 (Thursday) | 49,367 | USD 2,038,363 | USD 2,038,363 | | | | |
| 2025-01-08 (Wednesday) | 49,367 | USD 2,038,363 | USD 2,038,363 | | | | |
| 2025-01-08 (Wednesday) | 49,367 | USD 2,038,363 | USD 2,038,363 | | | | |
| 2025-01-08 (Wednesday) | 49,367 | USD 2,038,363 | USD 2,038,363 | | | | |
| 2025-01-02 (Thursday) | 50,179 | USD 2,078,916 | USD 2,078,916 | | | | |
| 2024-12-30 (Monday) | 50,179 | USD 1,939,418 | USD 1,939,418 | | | | |
| 2024-12-18 (Wednesday) | 50,179 | USD 2,060,350 | USD 2,060,350 | | | | |
| 2024-12-10 (Tuesday) | 49,715 | USD 2,420,126 | USD 2,420,126 | 0 | USD -57,670 | USD 48.68 | USD 49.84 |
| 2024-12-09 (Monday) | 49,715 | USD 2,477,796 | USD 2,477,796 | 4,176 | USD 94,740 | USD 49.84 | USD 52.33 |
| 2024-12-06 (Friday) | 45,539 | USD 2,383,056 | USD 2,383,056 | 0 | USD 128,420 | USD 52.33 | USD 49.51 |
| 2024-12-05 (Thursday) | 45,539 | USD 2,254,636 | USD 2,254,636 | 0 | USD -74,228 | USD 49.51 | USD 51.14 |
| 2024-12-04 (Wednesday) | 45,539 | USD 2,328,864 | USD 2,328,864 | 230 | USD 7,231 | USD 51.14 | USD 51.24 |
| 2024-12-03 (Tuesday) | 45,309 | USD 2,321,633 | USD 2,321,633 | 345 | USD -158,132 | USD 51.24 | USD 55.15 |
| 2024-12-02 (Monday) | 44,964 | USD 2,479,765 | USD 2,479,765 | 0 | USD 178,957 | USD 55.15 | USD 51.17 |
| 2024-11-29 (Friday) | 44,964 | USD 2,300,808 | USD 2,300,808 | 0 | USD 14,838 | USD 51.17 | USD 50.84 |
| 2024-11-28 (Thursday) | 44,964 | USD 2,285,970 | USD 2,285,970 | 0 | USD 0 | USD 50.84 | USD 50.84 |
| 2024-11-27 (Wednesday) | 44,964 | USD 2,285,970 | USD 2,285,970 | 0 | USD 68,795 | USD 50.84 | USD 49.31 |
| 2024-11-26 (Tuesday) | 44,964 | USD 2,217,175 | USD 2,217,175 | 0 | USD -49,011 | USD 49.31 | USD 50.4 |
| 2024-11-25 (Monday) | 44,964 | USD 2,266,186 | USD 2,266,186 | 0 | USD 113,310 | USD 50.4 | USD 47.88 |
| 2024-11-22 (Friday) | 44,964 | USD 2,152,876 | USD 2,152,876 | 0 | USD 71,492 | USD 47.88 | USD 46.29 |
| 2024-11-21 (Thursday) | 44,964 | USD 2,081,384 | USD 2,081,384 | 0 | USD -43,615 | USD 46.29 | USD 47.26 |
| 2024-11-20 (Wednesday) | 44,964 | USD 2,124,999 | USD 2,124,999 | 0 | USD 13,040 | USD 47.26 | USD 46.97 |
| 2024-11-19 (Tuesday) | 44,964 | USD 2,111,959 | USD 2,111,959 | 696 | USD 18,083 | USD 46.97 | USD 47.3 |
| 2024-11-18 (Monday) | 44,268 | USD 2,093,876 | USD 2,093,876 | 232 | USD -140,070 | USD 47.3 | USD 50.73 |
| 2024-11-12 (Tuesday) | 44,036 | USD 2,233,946 | USD 2,233,946 | 460 | USD -156,633 | USD 50.73 | USD 54.86 |
| 2024-11-11 (Monday) | 43,576 | USD 2,390,579 | USD 2,390,579 | 115 | USD 147,122 | USD 54.86 | USD 51.62 |
| 2024-11-08 (Friday) | 43,461 | USD 2,243,457 | USD 2,243,457 | 0 | USD -11,300 | USD 51.62 | USD 51.88 |
| 2024-11-07 (Thursday) | 43,461 | USD 2,254,757 | USD 2,254,757 | 575 | USD 79,579 | USD 51.88 | USD 50.72 |
| 2024-11-06 (Wednesday) | 42,886 | USD 2,175,178 | USD 2,175,178 | 0 | USD 15,439 | USD 50.72 | USD 50.36 |
| 2024-11-05 (Tuesday) | 42,886 | USD 2,159,739 | USD 2,159,739 | 0 | USD -9,864 | USD 50.36 | USD 50.59 |
| 2024-11-04 (Monday) | 42,886 | USD 2,169,603 | USD 2,169,603 | 0 | USD -7,290 | USD 50.59 | USD 50.76 |
| 2024-11-01 (Friday) | 42,886 | USD 2,176,893 | USD 2,176,893 | 0 | USD 187,411 | USD 50.76 | USD 46.39 |
| 2024-10-31 (Thursday) | 42,886 | USD 1,989,482 | USD 1,989,482 | 0 | USD -66,044 | USD 46.39 | USD 47.93 |
| 2024-10-30 (Wednesday) | 42,886 | USD 2,055,526 | USD 2,055,526 | 0 | USD -43,315 | USD 47.93 | USD 48.94 |
| 2024-10-29 (Tuesday) | 42,886 | USD 2,098,841 | USD 2,098,841 | 0 | USD -33,022 | USD 48.94 | USD 49.71 |
| 2024-10-28 (Monday) | 42,886 | USD 2,131,863 | USD 2,131,863 | 0 | USD 100,782 | USD 49.71 | USD 47.36 |
| 2024-10-25 (Friday) | 42,886 | USD 2,031,081 | USD 2,031,081 | 0 | USD -25,303 | USD 47.36 | USD 47.95 |
| 2024-10-24 (Thursday) | 42,886 | USD 2,056,384 | USD 2,056,384 | 0 | USD 83,628 | USD 47.95 | USD 46 |
| 2024-10-23 (Wednesday) | 42,886 | USD 1,972,756 | USD 1,972,756 | 230 | USD -76,438 | USD 46 | USD 48.04 |
| 2024-10-22 (Tuesday) | 42,656 | USD 2,049,194 | USD 2,049,194 | 0 | USD -20,049 | USD 48.04 | USD 48.51 |
| 2024-10-21 (Monday) | 42,656 | USD 2,069,243 | USD 2,069,243 | 0 | USD -17,489 | USD 48.51 | USD 48.92 |
| 2024-10-18 (Friday) | 42,656 | USD 2,086,732 | USD 2,086,732 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of CRSP by Blackrock for IE00BF4RFH31
Show aggregate share trades of CRSP| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-03-12 | SELL | -232 | | | 43.490* | | 46.79 Profit of 10,856 on sale |
| 2025-03-04 | SELL | -230 | | | 43.450* | | 47.03 Profit of 10,818 on sale |
| 2025-02-26 | SELL | -460 | | | 44.400* | | 47.27 Profit of 21,743 on sale |
| 2025-02-13 | BUY | 117 | | | 43.490* | | 47.03 |
| 2025-02-12 | BUY | 468 | | | 43.300* | | 47.10 |
| 2025-01-27 | BUY | 116 | | | 41.850* | | 49.07 |
| 2025-01-23 | BUY | 116 | | | 44.230* | | 49.36 |
| 2024-12-09 | BUY | 4,176 | | | 49.840* | | 49.69 |
| 2024-12-04 | BUY | 230 | | | 51.140* | | 49.55 |
| 2024-12-03 | BUY | 345 | | | 51.240* | | 49.49 |
| 2024-11-19 | BUY | 696 | | | 46.970* | | 49.43 |
| 2024-11-18 | BUY | 232 | | | 47.300* | | 49.55 |
| 2024-11-12 | BUY | 460 | | | 50.730* | | 49.48 |
| 2024-11-11 | BUY | 115 | | | 54.860* | | 49.12 |
| 2024-11-07 | BUY | 575 | | | 51.880* | | 48.71 |
| 2024-10-23 | BUY | 230 | | | 46.000* | | 48.28 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of CRSP
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-03-13 | 246,465 | 1,547 | 560,179 | 44.0% |
| 2025-03-12 | 246,042 | 1,456 | 483,111 | 50.9% |
| 2025-03-11 | 467,753 | 5,259 | 896,872 | 52.2% |
| 2025-03-10 | 594,939 | 679 | 1,117,595 | 53.2% |
| 2025-03-07 | 365,622 | 4,879 | 898,154 | 40.7% |
| 2025-03-06 | 236,671 | 1,013 | 595,508 | 39.7% |
| 2025-03-05 | 168,462 | 1,166 | 455,374 | 37.0% |
| 2025-03-04 | 325,388 | 835 | 858,500 | 37.9% |
| 2025-03-03 | 362,240 | 2,288 | 816,174 | 44.4% |
| 2025-02-28 | 251,200 | 954 | 712,408 | 35.3% |
| 2025-02-27 | 234,669 | 1,615 | 685,141 | 34.3% |
| 2025-02-26 | 164,096 | 277 | 543,872 | 30.2% |
| 2025-02-25 | 275,660 | 1,043 | 1,013,999 | 27.2% |
| 2025-02-24 | 203,883 | 3,230 | 910,290 | 22.4% |
| 2025-02-21 | 522,334 | 15,395 | 1,283,671 | 40.7% |
| 2025-02-20 | 530,951 | 2,453 | 1,373,242 | 38.7% |
| 2025-02-19 | 978,357 | 3,522 | 2,152,975 | 45.4% |
| 2025-02-18 | 1,260,452 | 2,180 | 2,760,773 | 45.7% |
| 2025-02-14 | 1,477,085 | 6,104 | 3,618,864 | 40.8% |
| 2025-02-13 | 501,494 | 269 | 908,428 | 55.2% |
| 2025-02-12 | 970,868 | 796 | 1,944,891 | 49.9% |
| 2025-02-11 | 505,179 | 473 | 1,083,716 | 46.6% |
| 2025-02-10 | 338,042 | 248 | 624,668 | 54.1% |
| 2025-02-07 | 549,571 | 327 | 1,034,674 | 53.1% |
| 2025-02-06 | 347,803 | 457 | 726,933 | 47.8% |
| 2025-02-05 | 378,361 | 141 | 974,179 | 38.8% |
| 2025-02-04 | 322,680 | 192 | 737,534 | 43.8% |
| 2025-02-03 | 396,073 | 1,871 | 997,154 | 39.7% |
| 2025-01-31 | 427,262 | 417 | 1,037,271 | 41.2% |
| 2025-01-30 | 297,123 | 312 | 859,240 | 34.6% |
| 2025-01-29 | 174,186 | 357 | 602,601 | 28.9% |
| 2025-01-28 | 148,210 | 273 | 692,575 | 21.4% |
| 2025-01-27 | 308,925 | 681 | 764,353 | 40.4% |
| 2025-01-24 | 331,451 | 749 | 1,220,126 | 27.2% |
| 2025-01-23 | 435,377 | 863 | 1,157,907 | 37.6% |
| 2025-01-22 | 1,104,388 | 1,686 | 2,926,003 | 37.7% |
| 2025-01-21 | 362,493 | 2,135 | 913,224 | 39.7% |
| 2025-01-17 | 309,046 | 683 | 670,886 | 46.1% |
| 2025-01-16 | 320,620 | 232 | 676,459 | 47.4% |
| 2025-01-15 | 366,525 | 5,802 | 805,439 | 45.5% |
| 2025-01-14 | 313,860 | 266 | 604,657 | 51.9% |
| 2025-01-13 | 596,537 | 3,941 | 1,233,983 | 48.3% |
| 2025-01-10 | 561,356 | 923 | 1,134,102 | 49.5% |
| 2025-01-08 | 213,367 | 152 | 465,778 | 45.8% |
| 2025-01-07 | 325,431 | 356 | 659,894 | 49.3% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.